Seth Harmon insider trades
Open-market stock purchases and sales by Seth Harmon, Chief Financial Officer at Viridian Therapeutics, Inc.\DE, from SEC Form 4 filings since Nov 10, 2023.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 3, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Bought (not open market) | — |
| Mar 3, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Sold (not open market) | $61.3K |
| Mar 3, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Sold (not open market) | $61.3K |
| Mar 2, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Bought (not open market) | — |
| Mar 2, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Bought (not open market) | — |
Companies traded
- VRDN Viridian Therapeutics, Inc.\DE: other filings, last Mar 3, 2026